Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
Drug and Therapeutics Committees - A Practical Guide
(2003; 155 pages) [French] [Spanish] [Vietnamese] View the PDF document
Table of Contents
View the documentAcronyms and abbreviations
View the documentPreface
Open this folder and view contents1. Introduction
Open this folder and view contents2.Structure and organization of a drug and therapeutics committee
Open this folder and view contents3. Managing the formulary process
Open this folder and view contents4.Assessing new medicines
Open this folder and view contents5.Ensuring medicine safety and quality
Open this folder and view contents6.Tools to investigate the use of medicines
Open this folder and view contents7.Promoting the rational use of medicines
Open this folder and view contents8.Antimicrobials and injections
Open this folder and view contents9. Getting started
View the documentGlossary1
View the documentReferences
View the documentFurther reading
View the documentUseful addresses and websites
View the documentBack cover
 

Acronyms and abbreviations

ABC

ABC analysis

ADR

adverse drug reaction

AGREE

Appraisal of Guidelines for Research and Evaluation in Europe

AHFS

American Hospital Formulary Service

AMR

antimicrobial resistance

ARR

absolute risk reduction

ASHP

American Society of Health-System Pharmacists

DALYs

disability-adjusted life years

DDD

defined daily dose

DTC

drug and therapeutics committee

DUE

drug use evaluation

DUR

drug utilization review

EDL

essential drugs list

EML

essential medicines list

EDLIZ

Essential Drug List of Zimbabwe

GMP

good manufacturing practices

IM

intramuscular

INN

International Nonproprietary Name

INRUD

International Network for Rational Use of Drugs

IV

intravenous

MCAZ

Medicines Control Authority of Zimbabwe

MI

myocardial infarction

MoH

Ministry of Health

MSH

Management Sciences for Health

MUE

medication use evaluation

NDTPAC

National Drug and Therapeutics Policy Advisory Committee

NNT

numbers needed to treat

QALYs

quality-adjusted life years

RCT

randomized controlled trial

RPM

Rational Pharmaceutical Management Project

RR

relative risk

RRR

relative risk reduction

SC

subcutaneous

SIGN

Scottish Intercollegiate Guidelines Network

SK

streptokinase

STG

standard treatment guideline

TB

tuberculosis

TPA

tissue plasminogen activator

UNFPA

United Nations Population Fund

UNICEF

United Nations Children’s Fund

VEN analysis

vital, essential and non-essential analysis

WHO

World Health Organization

 

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 29, 2018